ABO-incompatible living-donor kidney transplantation: Study of 48 patients after desensitisation.
CONCLUSIONS: ABO-incompatible living-donor kidney transplantation after conditioning with rituximab, plasmapheresis/immunoadsorption and immunoglobulins is a valid option offering excellent outcomes. There is a low incidence of acute rejection and no increase in infectious complications. An increased tendency for postoperative bleeding was found.
PMID: 31208833 [PubMed - as supplied by publisher]
Source: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia - Category: Urology & Nephrology Tags: Nefrologia Source Type: research
More News: Bleeding | Diabetes | Endocrinology | Kidney Transplant | Kidney Transplantation | Prednisone | Prograf | Proteinuria | Rituxan | Sodium | Study | Tacrolimus | Thrombosis | Transplant Surgery | Transplants | Urology & Nephrology